Skip to main content

Table 1 Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects

From: M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients

Study group   Number of patients
Epithelial ovarian cancer patients   110 (100%)
 • Median age (range)   58 (46–80)
-sub-type serous epithelial   61 (55%)
 • Median age (range)   58 (46–81)
-sub-type endometrioid epithelial   49 (45%)
 • Median age (range)   59 (48–86)
Tumor stage IA 6 (5.4%)
IB 8 (7.3%)
IC 14 (12.7%)
IIA 9 (8.2%)
IIB 10 (9.1%)
IIC 9 (8.2%)
IIIA 10 (9.1%)
IIIB 10 (9.1%)
IIIC 8 (7.3%)
IV (metastases) 26 (23.6%)
Menopausal status: - postmenopausal   110 (100%)
Benign ovarian tumor patients   70 (100%)
-type cystis serous   35 (50%)
-type cystis endometrioides   35 (50%)
Median age (range)   52 (48–68)
Menopausal status: - postmenopausal   70 (100%)
Healthy subjects   50 (100%)
Median age (range)   56 (48–66)
Menopausal status: - postmenopausal   50 (100%)